Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Frauke Muecksch and Theodora Hatziioannou.
Frauke Muecksch
Connection Strength
1.573
Theodora Hatziioannou
  1. Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations. Immunity. 2021 08 10; 54(8):1853-1868.e7.
    View in: PubMed
    Score: 0.240
  2. Longitudinal Serological Analysis and Neutralizing Antibody Levels in Coronavirus Disease 2019 Convalescent Patients. J Infect Dis. 2021 02 13; 223(3):389-398.
    View in: PubMed
    Score: 0.232
  3. Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID-19 Patients. J Clin Microbiol. 2020 11 18; 58(12).
    View in: PubMed
    Score: 0.228
  4. Publisher Correction: Bispecific IgG neutralizes SARS-CoV-2 variants and prevents escape in mice. Nature. 2021 Sep; 597(7874):E2.
    View in: PubMed
    Score: 0.060
  5. Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies. Nat Commun. 2021 07 07; 12(1):4196.
    View in: PubMed
    Score: 0.060
  6. Early treatment with a combination of two potent neutralizing antibodies improves clinical outcomes and reduces virus replication and lung inflammation in SARS-CoV-2 infected macaques. PLoS Pathog. 2021 07; 17(7):e1009688.
    View in: PubMed
    Score: 0.060
  7. Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection. Nature. 2021 07; 595(7867):426-431.
    View in: PubMed
    Score: 0.059
  8. Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants. Nature. 2021 07; 595(7866):278-282.
    View in: PubMed
    Score: 0.059
  9. Vaccine Breakthrough Infections with SARS-CoV-2 Variants. N Engl J Med. 2021 06 10; 384(23):2212-2218.
    View in: PubMed
    Score: 0.059
  10. Bispecific IgG neutralizes SARS-CoV-2 variants and prevents escape in mice. Nature. 2021 05; 593(7859):424-428.
    View in: PubMed
    Score: 0.059
  11. Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo. J Exp Med. 2021 03 01; 218(3).
    View in: PubMed
    Score: 0.058
  12. mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants. Nature. 2021 04; 592(7855):616-622.
    View in: PubMed
    Score: 0.058
  13. Evolution of antibody immunity to SARS-CoV-2. Nature. 2021 03; 591(7851):639-644.
    View in: PubMed
    Score: 0.058
  14. Enhanced SARS-CoV-2 neutralization by dimeric IgA. Sci Transl Med. 2021 01 20; 13(577).
    View in: PubMed
    Score: 0.057
  15. Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses. J Exp Med. 2020 11 02; 217(11).
    View in: PubMed
    Score: 0.057
  16. Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants. Elife. 2020 10 28; 9.
    View in: PubMed
    Score: 0.057
  17. Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies. Cell. 2020 08 20; 182(4):828-842.e16.
    View in: PubMed
    Score: 0.056
  18. Convergent antibody responses to SARS-CoV-2 in convalescent individuals. Nature. 2020 08; 584(7821):437-442.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.